Skip to main content
Premium Trial:

Request an Annual Quote

BioRegion Newsmakers: Feb 23, 2009

Premium

Executive Director Named for TECworks, New Entrepreneurial Support Program

Jan Bouten has been named executive director of TECworks, a new Memphis Bioworks Foundation program aimed at advancing support of biotech entrepreneurs and the commercialization of their technologies.

Bouten was formerly a venture partner with Aurora Funds, based in the Research Triangle area. He is the second Aurora Funds executive recruited to Tennessee in recent months, following Grant Jackson, who recently became a general partner at Nashville-based Council Ventures, the online business news service Venture Nashville reported.


Johns Hopkins Senior Scientist Joins Scientific Advisory Board of Commercialization Services Firm

David Silver, a senior scientist at the Johns Hopkins University Applied Physics Laboratory, has been appointed to the scientific advisory board of the commercialization services firm Transfer Technology International.

Silver has served as a professor of ophthalmology at the Wilmer Eye Institute, and as a visiting professor in ophthalmology at the University of Debrecen in Hungary. Silver’s research has spanned molecular physics, submarines, atmospheric chemistry, spacecraft, and ophthalmology. He is a co-inventor on three patents, and has played a role in developing and marketing various technologies.

Silver holds a BS from Illinois Institute of Technology, an MA from Johns Hopkins University, and a PhD from Iowa State University, and has held postdoctoral positions at Harvard University and the University of Paris.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.